EMulate Therapeutics Announces the Incorporation of A New Wholly Owned Subsidiary

Written By Kyle Kingma
Kyle Kingma
Previous

EMulate Therapeutics Announces the Publication of Positive Pre-clinical Data Evaluating Pain Reduction via Delivery of Low and Ultra-low Radio Frequency Energy
Next

EMulate Therapeutics Announces Promotion of Kyle Kingma to SVP, Finance, and GM, EMulate Subsidiaries - Corporate Update Announcement